Reneo Pharmaceuticals, Inc. Stock Company Profile
Information
18575 Jamboree Road, Suite 275-S
Irvine CA 92612
619 733 3852
reneopharma.com
Industry: Biotechnology
Sector: Healthcare
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.